Responsiveness to Change of 5-point MRC scale, Endurance and Functional Evaluation for Assessing Myositis in Daily Clinical Practice.

BACKGROUND Manual muscle testing has been widely used for the evaluation of muscle strength in myositis, yet less attention has been devoted to the evaluation of muscle function and endurance. OBJECTIVE Our objective was therefore to compare the responsiveness to change of muscle strength, endurance and functional testing following induction therapy for severe myositis flare (requiring high-dose corticosteroids and combined immunotherapy) in patients with a diagnosis of dermatomyositis, immune-mediated necrotizing myopathy, or overlap myositis. METHODS Muscle status was assessed at baseline and after mean 6.4±1.9 months, using the MRC-5 scale, along with endurance (Barre and Mingazzini maneuvers) and functional evaluation (e.g. chair rise) and responsiveness to change was evaluated using the Standardized Response Mean (SRM) and Standardized Mean Difference. RESULTS Among the 49 patients included, the strongest responsiveness to change was observed in the muscle testing of the psoas and deltoids (SRM: 1.23 and 1.16, respectively). Noticeably, endurance testing also demonstrated strong responsiveness (SRM: 1.05 and 0.96, respectively), compensating for the poor discriminatory ability of muscle testing and permitting to overcome its ceiling effect. CONCLUSION Functional and endurance testing provide simple and reliable measures complementing the testing of select proximal muscle groups to evaluate responsiveness to intervention in myositis patients in daily clinical practice. Interest of functional and endurance testing should be evaluated prospectively as outcome measures in myositis clinical trials.

[1]  A. Mammen,et al.  Muscle endurance deficits in myositis patients despite normal manual muscle testing scores , 2018, Muscle & nerve.

[2]  A. Mammen,et al.  224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016 , 2017, Neuromuscular Disorders.

[3]  J. Hogrel,et al.  Physical activity monitoring: A promising outcome measure in idiopathic inflammatory myopathies , 2017, Neurology.

[4]  S. Paganoni,et al.  Outcome measures in the idiopathic inflammatory myopathies , 2017, Neurology.

[5]  W. Stenzel,et al.  Advances in serological diagnostics of inflammatory myopathies. , 2016, Current opinion in neurology.

[6]  Oakley,et al.  213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18–20 September 2015 , 2016, Neuromuscular Disorders.

[7]  K. Wadell,et al.  Correlation between Limb Muscle Endurance, Strength, and Functional Capacity in People with Chronic Obstructive Pulmonary Disease , 2016, Physiotherapy Canada. Physiotherapie Canada.

[8]  L. Servais,et al.  Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: Implications for therapeutic trials , 2014, Neuromuscular Disorders.

[9]  T. Voit,et al.  Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients , 2013, Neuromuscular Disorders.

[10]  Alan Tennant,et al.  Modifying the Medical Research Council grading system through Rasch analyses , 2011, Brain : a journal of neurology.

[11]  David Hilton-Jones,et al.  Long-term observational study of sporadic inclusion body myositis. , 2011, Brain : a journal of neurology.

[12]  B. Feldman,et al.  Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies , 2010, Arthritis care & research.

[13]  D. Koziol,et al.  Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. , 2009, Rheumatology.

[14]  I. Lundberg,et al.  Functional index-2: Validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis. , 2006, Arthritis and rheumatism.

[15]  I. Targoff,et al.  Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies: Analysis of 100 French Canadian Patients , 2005, Medicine.

[16]  A. Windebank,et al.  History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation , 2005, Journal of the peripheral nervous system : JPNS.

[17]  R. Hughes,et al.  119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands , 2004, Neuromuscular Disorders.

[18]  W. Kuis,et al.  Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. , 2003, Rheumatology.

[19]  S. Chevret,et al.  Standards of Measurements in Myasthenia Gravis , 2003, Annals of the New York Academy of Sciences.

[20]  P. Lachenbruch,et al.  Defining Clinical Improvement in Adult and Juvenile Myositis. , 2003, The Journal of rheumatology.

[21]  G. Huberfeld,et al.  Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis , 2000, Journal of Neurology.

[22]  L. Pachman,et al.  Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. , 1999, Arthritis and rheumatism.

[23]  J Drukker,et al.  Quadriceps strength and timed motor performances in myotonic dystrophy, Charcot–Marie–Tooth disease, and healthy subjects , 1998, Clinical rehabilitation.

[24]  S. Dimauro,et al.  Inclusion body myositis and myopathies , 1995, Annals of neurology.

[25]  F. P. Kendall,et al.  Muscles, testing and function , 1971 .

[26]  April.  AIDS TO THE INVESTIGATION OF PERIPHERAL NERVE INJURIES , 1943 .